RNase moonlights as a cancer instigator

Qing Zhang

doi:10.1126/scitranslmed.aat3892

RNase moonlights as a cancer instigator

Qing Zhang

Research output: Contribution to journal › Review article › peer-review

Abstract

RNase 5 is a bona fide EGFR ligand that promotes oncogenic transformation in pancreatic cancer.

Original language	English (US)
Article number	aat3892
Journal	Science Translational Medicine
Volume	10
Issue number	436
DOIs	https://doi.org/10.1126/scitranslmed.aat3892
State	Published - Apr 11 2018
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1126/scitranslmed.aat3892

Cite this

@article{f7eb35b769d5498bba8690f318ccd250,

title = "RNase moonlights as a cancer instigator",

abstract = "RNase 5 is a bona fide EGFR ligand that promotes oncogenic transformation in pancreatic cancer.",

author = "Qing Zhang",

year = "2018",

month = apr,

day = "11",

doi = "10.1126/scitranslmed.aat3892",

language = "English (US)",

volume = "10",

journal = "Science Translational Medicine",

issn = "1946-6234",

publisher = "American Association for the Advancement of Science",

number = "436",

}

TY - JOUR

T1 - RNase moonlights as a cancer instigator

AU - Zhang, Qing

PY - 2018/4/11

Y1 - 2018/4/11

N2 - RNase 5 is a bona fide EGFR ligand that promotes oncogenic transformation in pancreatic cancer.

AB - RNase 5 is a bona fide EGFR ligand that promotes oncogenic transformation in pancreatic cancer.

UR - http://www.scopus.com/inward/record.url?scp=85045329716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045329716&partnerID=8YFLogxK

U2 - 10.1126/scitranslmed.aat3892

DO - 10.1126/scitranslmed.aat3892

M3 - Review article

AN - SCOPUS:85045329716

SN - 1946-6234

VL - 10

JO - Science Translational Medicine

JF - Science Translational Medicine

IS - 436

M1 - aat3892

ER -

RNase moonlights as a cancer instigator

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this